Pulmatrix, Inc. (PULM)
Develops inhaled medications for migraines and lung diseases using a powder delivery technology.
$1.68-0.02%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-68.5%
The outlook
PULM is trading near the lower end of its 52-week range at $1.68, sitting just 11% above its yearly low. The stock shows mixed momentum against its moving averages, and analyst sentiment leans bearish overall. Current data suggests cautious positioning from market observers.
What’s behind the score
Price trendMixed vs its moving averages
52-week range11% of the way from its 52-week low to high
Market cap
$6.1M
52-wk high
$5.77
52-wk low
$1.16
50-day avg
$1.52
200-day avg
$2.57
Trailing P/E
—